Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

by Payam Nahid, Erin E Bliven, Elizabeth Y Kim, William R Mac Kenzie, Jason E Stout, Lois Diem, John L Johnson, Sebastien Gagneux, Philip C Hopewell, Midori Kato-Maeda, Tuberculosis Trials Consortium
Published 2010-05-01

Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.

by Melissa R Nyendak, Byung Park, Megan D Null, Joy Baseke, Gwendolyn Swarbrick, Harriet Mayanja-Kizza, Mary Nsereko, Denise F Johnson, Phineas Gitta, Alphonse Okwera, Stefan Goldberg, Lorna Bozeman, John L Johnson, W Henry Boom, Deborah A Lewinsohn, David M Lewinsohn, Tuberculosis Research Unit and the Tuberculosis Trials Consortium
Published 2013-01-01

Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis

by Sharlaa Badal-Faesen, Cynthia Firnhaber, Michelle A. Kendall, Xingye Wu, Beatriz Grinsztejn, Rodrigo Otavio da Silva Escada, Michel Fernandez, Evelyn Hogg, Ian Sanne, Pamela Johnson, David Alland, Gerald H. Mazurek, Debra A. Benator, Anne F. Luetkemeyer, the AIDS Clinical Trials Group A5295, Tuberculosis Trials Consortium Study 34 Teams
Published 2017-08-01